Nasdaq16d
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology
(RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind ...
Business Wire16d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent ...
Seeking Alpha21d
Qiagen N.V.: Some Clarity Needed Before Buying The Dip
Learn More » Qiagen N.V. is headquartered in the Netherlands. The company's product portfolio includes approximately 500 offerings ranging from sample technology consumables, kits and components ...